OSE · OSE IMMUNOTHERAPEUTICS · Short Interest
Market Cap
55.44M EUR
Shares
24.73M
Net short positions in OSE IMMUNOTHERAPEUTICS disclosed to the market regulator. Holders must report positions above the regulator's threshold, so these are disclosed positions, not total short interest, and absence is not a zero position.
Disclosed net short positions · France · AMF
Recent individual disclosures for ISIN FR0012127173. France AMF public disclosures; absence is not a zero position. Percentages refer to issued capital, not free float. These are not total short interest or a list of current positions. Public disclosures generally begin at 0.5% per holder. A disclosure below that threshold does not establish the holder's subsequent position.
| Position date | Holder | Issued capital | Published |
|---|---|---|---|
| 2024-10-07 | QUBE RESEARCH & TECHNOLOGIES LIMITED | 0.47% | 2024-10-08 |
| 2024-10-03 | QUBE RESEARCH & TECHNOLOGIES LIMITED | 0.55% | 2024-10-04 |
| 2024-10-02 | QUBE RESEARCH & TECHNOLOGIES LIMITED | 0.62% | 2024-10-03 |
| 2024-09-13 | QUBE RESEARCH & TECHNOLOGIES LIMITED | 0.73% | 2024-09-16 |
| 2024-09-12 | QUBE RESEARCH & TECHNOLOGIES LIMITED | 0.64% | 2024-09-13 |
| 2024-09-11 | QUBE RESEARCH & TECHNOLOGIES LIMITED | 0.54% | 2024-09-12 |
| 2021-06-02 | VOLEON CAPITAL MANAGEMENT LP | 0.49% | 2021-06-03 |
| 2021-05-28 | VOLEON CAPITAL MANAGEMENT LP | 0.5% | 2021-05-31 |
Checked 2026-10-08 00:20 UTC.
Showing 1–8 of 8 disclosures